Antivirals shared are a problem eased in the fight against Covid-19

As the world struggles to find a way to live with Covid-19, the preliminary results of two antiviral drugs offer some hope.Molnupiravir, a drug developed by Merck and Ridgeback Biotherapeutics, and Paxlovid by Pfizer are both pending approval in the United States while Britain has already given the go-ahead to molnupiravir.The Merck-Ridgeback medication can cut death and hospitalisations by half while the Pfizer treatment does so by 89 per cent, according to the companies.It is still too early…


See also  Chinese farmers create a buzz, and a living, through video-sharing apps

Leave a Reply